Barclays has said that it’s hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.
Trump’s Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It’s ‘Difficult’ To Predict As Drugmakers Have ‘Complex Supply Chains’
